Vext Science, Inc. (VEXTF)
OTCMKTS · Delayed Price · Currency is USD
0.2050
+0.0191 (10.27%)
Aug 12, 2025, 3:40 PM EDT
Vext Science Market Cap
Vext Science has a market cap or net worth of $60.82 million as of August 13, 2025. Its market cap has increased by 57.84% in one year.
Market Cap
60.82M
Enterprise Value
94.81M
Revenue
39.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.21
Market Cap Chart
Since May 13, 2019, Vext Science's market cap has decreased from 78.00M to 60.82M, a decrease of -22.02%. That is a compound annual growth rate of -3.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 60.82M | 114.34% |
| Dec 31, 2024 | 28.38M | -40.58% |
| Dec 29, 2023 | 47.76M | 80.79% |
| Dec 30, 2022 | 26.42M | -61.79% |
| Dec 31, 2021 | 69.14M | -22.72% |
| Dec 31, 2020 | 89.47M | 102.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.23M |
| Glass House Brands | 561.16M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 360.45M |
| CytoDyn | 300.75M |